AGP Executive Report
Last update: 10 hours agoVaccine Trial: Guinea-Bissau’s health minister says the government has not authorized a proposed hepatitis B study involving 14,000 newborns, despite reports that Danish researchers’ revised protocol received approval. The trial would delay the birth dose for half the babies until six weeks of age; the US health department also says it has not been approved. The ministry says research involving children must meet national law and international ethics standards.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.